Episode 106 - Gemma Guinart Mola - Principal at Invivo Partners

On this episode we're joined by Invivo Partners' Gemma Guinart, for a discussion into early-stage biotech investing.

Invivo Partners look to invest in compelling in-vivo proof of concept data, and back founding teams across Europe with pre-seed to Series A investment - recent investments from their third fund include Neumirna Tx & Signadori Bio.

Tune in to hear more about how Gemma & the team identify investment opportunities & why they focus on early-stage investments in a market that has recently leaned toward late-stage de-risked assets.

We also chat briefly through some potential pitfalls for founders looking for funding, their newest fund bridging healthcare & AI, and success stories from the Invivo Partners portfolio, including EsoBiotec.